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Abstract
The Ca2" responsiveness of vascular smooth muscle myofil-
aments is not unique: it is increased during neuro-humoral
activation and decreased during /3-adrenergic stimulation.
In this study we tested whether an augmented Ca2" respon-
siveness of smooth muscle myofilaments may contribute to
the increased coronary tone observed in hypertension using
/3-escin-permeabilized coronary arteries from 3-mo-old
stroke-prone spontaneously hypertensive rats (SHRSP) and
their age matched normotensive reference strain (WKY
rats). In intact coronary arteries, the response to 5-hydroxy-
tryptamine (5-HT) but not to KCI was larger in SHRSP
than in WKY rats. In (i-escin permeabilized coronary arter-
ies in which the receptor effector coupling is still intact, 5-
HT enhanced force at constant submaximal (Ca2") (pCa
6.38) to a greater extent in SHRSP. The Ca2" sensitizing
effect of 5-HT was mimicked by GTPyS (0.01-10 IAM);
again this effect was larger in SHRSP. In the absence of 5-
HT or GTPyS the Ca2" force relation was similar in both
groups. Forskolin induced relaxation at constant submaxi-
mal (Ca2"). This desensitizing effect was smaller in SHRSP
than in WKY rats. In conclusion, this study shows that
intracellular signalling pathways involved in modulating the
Ca2" responsiveness of coronary smooth muscle myofila-
ments are altered in the genetically hypertensive animals
favoring a hypercontractile state in the coronary circulation.
(J. Clin. Invest. 1994. 94:1397-1403.) Key words: stroke-
prone spontaneously hypertensive rat . permeabilized coro-
nary arteries * Ca2"-sensitivity * 5-hydroxytryptamine * for-
skolin
Introduction
In the past, efforts to reduce the high coronary morbidity and
mortality of patients with primary hypertension by antihyperten-
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sive treatment have failed to reduce the coronary risk in this
group of patients ( 1 ). This may reflect the fact, that the coronary
disease process associated with primary hypertension is still
poorly understood (2). Recent clinical (3, 4) and experimental
reports using spontaneously hypertensive rats (5) have focused
on the endothelial dysfunction as a possible cause of impaired
coronary flow in hypertension. However, the vascular smooth
muscle cells of the media may also contribute to a functionally
altered regulation of coronary tone as suggested by a number
of studies using isolated blood vessels obtained mainly from
the mesenteric vascular bed and the aorta of genetically hyper-
tensive rats (for reviews see references 6-8). It has been pro-
posed that not only structural modifications of the blood vessels
(6) but also alterations in the calcium homeostasis (7-9) of
the smooth muscle cells may contribute to an increased respon-
siveness to a number of vasoconstrictor agents. The altered
calcium homeostasis would ultimately lead to an increased
availability of calcium for the myofilaments (7).
However, neurohumoral stimulation of vascular smooth
muscle not only leads to an increase in the cytoplasmic Ca2+
concentration. It also increases the Ca2+ sensitivity of the myo-
filaments as has been demonstrated in a number of laboratories
during the last decade (10-13). If the agonist induced Ca2+
sensitization of the myofilaments were augmented in hyperten-
sion this would then also contribute to an increased vasocon-
strictor response. Such an augmented Ca2+ sensitization rather
than alterations in the Ca2' homeostasis of the smooth muscle
cells may in fact underlie the higher sensitivity to extracellular
Ca2" of norepinephrine-induced contractions in intact mesen-
teric resistance arteries of spontaneously hypertensive rats ( 14).
We therefore tested the hypothesis that the agonist induced Ca2+
sensitization of the smooth muscle myofilaments is augmented
in coronary arteries from stroke-prone spontaneously hyperten-
sive rats (SHRSP)' as compared with their normotensive refer-
ence strain, the Wistar Kyoto (WKY) rats (15). We chose 5-
hydroxytryptamine (5-HT) as an agonist because in vivo it may
be released from activated platelets (16) and it is capable of
reducing coronary flow in perfused spontaneously hypertensive
rat hearts (5).
Agonist-induced Ca2+ sensitization of smooth muscle myo-
filaments as well as the signalling cascade involved may be
investigated in blood vessels permeabilized with ,6-escin (17).
In these preparations, the receptor-effector coupling is function-
ally intact while the ionic composition, in particular (Ca2+),
1. Abbreviations used in this paper: 5-HT, 5-hydroxytryptamine; G
protein, guanosine nucleotide binding protein; GTP, guanosine triphos-
phate; GTP/S3, guanosine-5'-0-(3-thiodiphosphate); GTPyS, gua-
nosine-5'-0-(3-thiotriphosphate); PSS, physiological salt solution;
SHRSP, stroke-prone spontaneously hypertensive rats; WKY, Wistar
Kyoto.
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may be clamped and small molecules such as nucleotides may
be diffused into the smooth muscle cells. The agonist induced
Ca2" sensitization appears to be mediated by a G protein-
coupled mechanism as it is mimicked by the nonhydrolyzable
GTP analog, GTPyS, which permanently activates G proteins
(17-19). Downstream events may involve inhibition of myosin
light chain phosphatase (20, 21 ) and activation of protein kinase
C (PK-C, 22, 23).
In this study we show that in f3-escin permeabilized coro-
nary arteries from SHRSP and WKY rats, 5-HT increases the
Ca2+ sensitivity of the myofilaments and this effect is more
pronounced in the genetically hypertensive rats. The effect of
5-HT on Ca2" sensitivity of force is mimicked by GTPyS.
Again, the effect of GTPyS is larger in the coronary arteries
from SHRSP. In contrast, in the absence of 5-HT or GTPyS,
the Ca2+ sensitivity of the myofilaments is not different between
SHRSP andWKY rats (see reference 24). This suggests that the
G protein effector coupling within the coronary artery smooth
muscle cells involved in modulating Ca2" sensitivity of force
production may differ between genetically hypertensive and
normotensive rats. This finding points to a novel mechanism
contributing to the hyperresponsiveness of coronary arteries of
SHRSP which is not related to altered Ca2' homeostasis or
endothelial dysfunction.
Methods
Animals. 12-14-wk-old male rats were obtained from the colony at the
Pharmacology Department of the University of Heidelberg (15). The
body weight of the SHRSP rats was 236±26 g (n = 11) and that of
the WKY rats 315±24 g (n = 12). Systolic blood pressure was mea-
sured before the experiments by tail plethysmography during light ether
anesthesia. The values were (mm Hg): 182±20 in SHRSP and 112± 14
in WKY rats (P < 0.05).
Force measurements. Rats were anesthetized with ether and bled.
First or second branches of the left coronary arteries (outer in situ
diameter in ,um; 135±19 in SHRSP, 144±21 in WKY rats) were dis-
sected in physiological salt solution (PSS) of the following composition
(mM): NaCl 118, KCl 5, Na2HPO4 1.1, MgCl2 1.2, CaCl2 1.6, Hepes
24 (pH 7.4 at 25°C) and glucose 10. PSS was gassed with 100% 02-
Ring segments were mounted on a myograph (AME 801 force trans-
ducer, Horten Norway) as described previously (25, 26). The mounting
technique did not denude the vessels from the endothelium as judged
by light microscopic examination of the vessels subjected to morphome-
try. The endothelium appeared to be functional in the intact vessels as
precontraced vessels were relaxed by ADP. The ADP (10 AM) induced
relaxation of vessels precontracted with 1 sM 5-HT amounted to
82±11% and 46±15% (n = 8) in WKY and SHRSP rats, respectively.
In f3-escin-permeabilized preparations, the endothelium is not func-
tional because of the treatment with detergent and the presence of di-
thioerythritol in the incubation solutions (27). The vessels were
stretched to an optimum length at which the force induced by 125 mM
KCl became maximum. On completion of the experiments in intact
preparations, the vessels were permeabilized by treatment with /-escin
according to the method of Kobayashi et al. (17). Briefly, the coronary
arteries were incubated for 20 min in Ca2+-free PSS followed by 10
min in relaxing solution. They were then incubated with 50 ,Ag/ml ,/-
escin for 30 min at 25°C in relaxing solution. The relaxing solution
contained (in mM): imidazole 20, EGTA 4, ATP 7.5, potassium meth-
anesulfonate 110, magnesium acetate 10, NaN3 1, creatine phosphate
10, creatine kinase 100 U/ml, at pH 7.0. The contracting solution con-
tained in addition 4 mM CaCl2. Alterations of the free Ca2+ concentra-
tion (calculated as in 26) were obtained by mixing contracting and
relaxing solution in the appropriate ratio. All solutions contained in
addition calmodulin (1 1M), leupeptin (1 sM), and dithioerythritol
(DTE 2 mM). To deplete the sarcoplasmic reticulum of calcium and
maintain cytoplasmic (Ca2") constant, every vessel was also treated
with 10 ,M A23187 for 20 min in the relaxing solution.
Morphometry. The vessel dimensions were measured in (a) arteries
that had been subjected to the mechanical experiments and (b) following
retrograde perfusion fixation of the hearts in situ under constant pressure.
On completion of the mechanical experiments, the /3-escin-perme-
abilized arteries were completely relaxed in relaxing solution (see
above), fixed overnight at room temperature in phosphate-buffered (0.1
M, pH 7.4) glutaraldehyde (2.5%) and stored in the fixative at 40C.
The vessels were dehydrated with ethanol and propyleneoxide, and em-
bedded in Epon. Cross-sections out of the middle of the segments (2
1sm thick) were mounted on glass slides and stained with Stevenel's
Blue (28) and basic fuchsin. The slides were examined on a standard
microscope (Polyvar 2, Leica, Germany). Morphological measurements
were made on 7 segments out of 4 WKY rats and on 8 segments out
of 4 SHRSP.
To measure the vessel dimensions in situ, four hearts of each group
were perfused retrograde for 2 min with a modified Krebs-Henseleit
solution containing (mM): NaCl 114.7, KCl 4.7, MgSO4 1.2, KH2PO4
1.5, NaHCO3 25, CaCl2 2.5, glucose 11.1, and 10 iM adenosine, gassed
with 95% 02 and 5% CO2, pH 7.4, at a constant pressure of 90 mm
Hg at room temperature. This was followed by a 3-5 min perfusion at
90 mm Hg with 2.5% glutaraldehyde in 0.1 mM phosphate buffer, pH
7.4. A 3-mm-thick transverse slice was cut out of the medial third
section of the heart (corresponding to the site where the vessels for
the mechanical experiments were obtained) and was embedded with
historesinTm (Cambridge Instruments, Cambridge, MA). The slice was
cut into 2-tpm-thick cross sections, mounted on glass slides and stained
with hematoxylin (hematoxylin solution Gill No. 3; Sigma Diagnostics,
St. Louis, MO) and eosin. Morphological measurements were made on
2-4 vessels per heart.
Morphological analysis was performed at a magnification of 400
using a digitizing tablet interfaced to an IBM compatible personal com-
puter running the program Sigma Scan (Jandel Scientific GmbH, Erk-
rath, Germany). The length of the internal elastic lamina and the cross-
sectional area of the media were measured with the help of a drawing
tube. The mean of three measurements of the limits of the vessels was
used for further calculations. Using the method described by Furuyama
(29) the thickness of the vessel wall (media thickness), the luminal
diameter and the wall/lumen ratio were calculated for a standardized
condition, in which the internal elastic membrane is smooth and circular.
Because of oblique sections of coronary vessels in the cross section of
the heart, the dimension of the in situ fixed vessel wall was determined
as the ratio of surface area of the media to surface area of the vessel
(= area of the lumen + area of the media) (30).
Calculations and statistics. To make comparisons between different
vessel segments possible, forces (mN) were divided by the product of
the longitudinal length (J.m) and the internal circumference (C, in tim)
to obtain mN per mm2 as described previously by Boels et al. (25).
The internal circumference was calculated according to Hogestatt
et al. (31): C = 2 L + (ir + 2) D, where D is the diameter of the
wires and L the distance between them. All values were expressed as
means±SEM, with n indicating the number of experiments. Difference
of responsiveness among groups was tested by the one way analysis of
variance (32), followed by paired or unpaired Student's t test as appro-
priate (one sided). P values < 0.05 were considered to indicate signifi-
cant differences.
Drugs. Forskolin and 5-hydroxytryptamine hydrochloride (5-HT)
were from Sigma Chemical Co., St. Louis, MO). GTP, guanosine-5'-
0-(3-thiotriphosphate) (GTPyS), and guanosine-5 '-0-(2-thiodiphos-
phate) (GDPlS) were obtained from Boehringer Mannheim, Germany.
Forskolin was dissolved in methyl sulfoxide (DMSO); the final concen-
tration of DMSO was less than 1%, which did not affect force.
Results
Morphological characteristics of the coronary arteries. In /3-
escin-permeabilized coronary arteries, fixed completely re-
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Table L Light Microscopic Measurements of Coronary Arteries
WKY SHRSP
Permeabilized vessels
Media diameter (pm) 14.2±1.6 14.9±1.0
Lumen diameter (prm) 134.4±9 134.4±9
Ratio media/lumen 0.1±0.01 0.11±0.01
Area of the media (X102 Om2) 68.6± 10.4 70.8±7.9
Area of the lumen (x102 im2) 68±5 65±6
Ratio area media/area vessel 0.48±0.04 0.52±0.02
In situ fixed intact vessels
Lumen diameter (pm) 260±50 232+22
Area of the media (X102 1Im2) 270±50 230±30
Area of the lumen (X102 Ym2) 610±130 470±80
Ratio area media/area vessel 0.34±0.03 0.36±0.03
The permeabilized vessels were fixed in the myograph completely re-
laxed at the end of the mechanical experiment while the intact vessels
were fixed in situ under retrograde constant pressure perfusion in the
presence of adenosine. In permeabilized preparations 7 segments from
4 WKY rats and 8 segments from 4 SHRSP were investigated. In
perfused hearts (four of each group) 2-4 vessels per animal were exam-
ined in a coronal section out of the medial third of the heart. The mean
values of the vessel dimensions of the in situ fixed arteries are larger
as vessels up to a diameter of 430 yrnm were analyzed. Values are
mean±SEM, no statistically significant difference could be detected
between SHRSP and WKY rats.
laxed in the myograph at the end of the experiment, no signifi-
cant morphological difference between SHRSP and WKY rats
could be detected (Table I). There was, however, some uncer-
tainty in determining the media thickness in the permeabilized
preparations as the cytoplasm was stained weakly. This made
the identification of the boundary between media and adventitia
somewhat ambiguous. For this reason we also analyzed coro-
nary arteries fixed in situ under constant pressure perfusion
and maximal vasodilation induced with adenosine (30). Again,
there was no significant difference between SHRSP and WKY
rats (Table I). The lumen diameters of the arteries measured
in situ ranged from 80 to 430 1Am. The mean lumen diameters
were higher than the mean lumen diameters of the permeabil-
ized coronary arteries, because of large vessels in the coronal
section of the heart. Again, there were no significant differences
between SHRSP and WKY after subdividing the vessels into
two size classes with lumen diameters > 250 and < 250 ,im.
Mechanical experiments in intact coronary arteries. Fig. 1
shows representative tension responses to stimulation with KCl
(125 mM) and 5-HT (3 AM). Tension response to KCl was
biphasic with a rapid initial rise in force which was followed
by a tonic component which was not significantly different
between WKY and SHRSP rats (5.52+0.68 mN/mm2 in WKY
rats and 6.12±0.64 mN/mm2 in SHRSP, n = 8 each). 5-HT
elicited monophasic tonic contractions in the presence of extra-
cellular Ca2+ (Fig. 1). In the absence of extracellular Ca2 ,
only small and transient contractions were induced by 5-HT
(Fig. 1). Peak force elicited by 3 ,uM 5-HT was 5±2% in WKY
rats and 11±4% in SHRSP (n = 8) of that in the presence of
Ca2+; the difference was not statistically significant.
Fig. 2 shows the dose-response relationship for 5-HT in the
presence of extracellular Ca2 . Coronary arteries from SHRSP
rats showed a significantly higher efficacy of the response to
1.6 mM (Ca2i0
WKY
SHRSP
125 mM KCI 3pM 5-HT
Ca2+- free
(+ 1 mM EGTA)
J0.5 mN
6 min
3 M 5-HT
3 pM 5-HT
Figure 1. Tension responses in intact coronary arteries of SHRSP and
WKY rats. Representative tension responses in intact coronary arteries
to stimulation with KCl and 5-HT in the presence of extracellular Ca2"
([Ca2+] = 1.6 mM, left two tracings), and in Ca2+-free PSS with 1
mM EGTA (on the right side). Tension elicited by KCI was 5.52±0.68
MN/MM2 in WKY and 6.12±0.64 mN/mm2 in SHRSP (mean±SEM,
n = 8, not significantly different).
remained when force was expressed relative to the tension elic-
ited by KCl (Fig. 2 B). However, the sensitivity of the response
to 5-HT was not increased; the ECm values in SHRSP and
WKY rats were similar (EC50 = 0.16 jM in SHRSP and 0.18
juM in WKY rats).
Mechanical experiments in permeabilized coronary arter-
ies. In f3-escin-permeabilized preparations, maximal force elic-
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Figure 2. Dose-re-
sponse curves to 5-HT in
intact coronary arteries.
The response to 5-HT is
significantly larger in
SHRSP (i) than in
WKY rats (o), both
when expressed as abso-
lute force (A) and when
expressed as percent of
the force elicited by KCI
(B). The dose-response
curves were obtained
noncumulatively, i.e., the
vessels were relaxed be-
tween each challenge of
5-HT. Each point is ex-
pressed as the
mean±SEM for eight ob-
servations.
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Figure 3. Force-pCa relations in f-escin-skinned coronary arteries
from SHRSP (e) and WKY rats (0). The vessels were contracted by
cumulatively increasing concentrations of Ca2" in the presence of 1 ktM
calmodulin. Values were normalized to force at pCa 4.8. Each point is
expressed as the mean±SEM for four observations.
ited by pCa 4.8 was not different between WKY and SHRSP
and amounted respectively to 125±10% and 134±12% of the
force developed in response to KCl in the intact preparation.
There was also no difference in the Ca2+ sensitivity of tension
development; pCa50 was 6.31 in both groups (Fig. 3).
In a second series of experiments we tested whether 5-HT
and GTPyS increased Ca2+ responsiveness and whether this
effect was larger in SHRSP. A submaximal contraction was
elicited by pCa 6.38 (in the presence of 100 MM GTP, cf. Fig.
4A) which amounted to 30±7% (WKY) and 28±3% (SHRSP)
of the maximal response elicited by pCa 4.8 (n = 6). 5-HT (in
the continued presence of GTP) enhanced submaximal force
concentration dependently at constant (Ca2+) (Fig. 4). The
Ca2+-sensitizing effect of 5-HT was reversible and was inhib-
ited by GDPPS (Fig. 4 A). The degree of force enhancement
was significantly larger in SHRSP than in WKY rats and was
shifted to lower concentrations (Fig. 4 B).
We then tested whether the Ca2+ sensitizing effect of 5-
HT was mimicked by GTPyS. In these experiments, the blood
vessels were activated with pCa 6.38 in the absence of GTP
followed by incubation with cumulatively increasing concentra-
tions of GTPyS. The Ca2+-activated force in WKY rats and
SHRSP was respectively 28±5% and 25 ±5% of maximal force.
GTPyS modified neither resting force nor maximal force but
enhanced submaximal Ca2' activated force in both groups con-
centration dependently whereby the effect was larger in SHRSP
(Fig. 5). The threshold concentration of GTPyS was also lower
in SHRSP. Interestingly, in both groups the dose response rela-
tion was biphasic, i.e., 10 MM GTPyS was less effective than
1 uM GTPyS (Fig. 5).
GTPyS nonspecifically activates all heterotrimeric G pro-
teins, i.e., also G,. the stimulation of which leads to accumula-
tion ofcAMP through activation of adenylyl cyclase. Activation
of the cAMP pathway in intact smooth muscle (33) and incuba-
tion of skinned coronary arteries with the catalytic subunit of the
cAMP dependent protein kinase (34) leads to desensitization of
the myofilaments to Ca2 . We therefore tested whether direct
activation of the adenylyl cyclase by forskolin affects force in /-
escin-permeabilized coronary arteries. The blood vessels were
A 0.5mN 1mM GDPP3S
< <~~~6min A
5-HT lpM 5-HT
pCa 6.38 pCa 6.38+100pM GTP
+ 100 pM GTP
B
C
0
7o
C
.~! 1.25-
0J
1.00
control WKY SHRSP WKY SHRSP
Figure 4. 5-HT increases force in ,3-escin-permeabilized coronary arter-
ies at constant submaximal (Ca2+). (A) Original force tracing of a
vessel from SHRSP. Following activation with pCa 6.38 in the presence
of GTP, 5-HT was added which increased force concentration depen-
dently. The effect was reversed by GDP#3S. B: Increase in Ca 2+ respon-
siveness expressed relative to the force elicited by pCa 6.38 with GTP
(control) in the presence of 0.1 ILM 5-HT (left columns) and 1 OM 5-
HT (right columns). Values are means±SEM for six observations;
**significant increase in Ca2' responsiveness as well as significant
difference between SHRSP and WKY rats (P < 0.05). *In WKY rats,
there is only a significant increase in Ca2' responsiveness in the presence
of 1 jLM 5-HT (P < 0.05).
again submaximally activated (pCa 6.38). Once force had
reached a plateau, forskolin (10 MM) was added which induced
a partial relaxation at constant Ca2+ (Fig. 6). In WKY rats the
relaxing effect of forskolin on force was larger than in the
SHRSP (Fig. 6).
Discussion
The major finding of this study is, that 5-HT and GTPyS en-
hanced the Ca2' responsiveness of force in f3-escin-permeabil-
ized coronary arteries from SHRSP to a greater extent than in
their normotensive reference strain, the WKY rats. This aug-
mented Ca2+ sensitization may underlie the increased respon-
siveness to stimulation with 5-HT observed in intact coronary
arteries from the hypertensive animals. We also show that for-
skolin is less effective in decreasing force at constant (Ca2")
in (-escin-permeabilized coronary arteries from SHRSP. These
findings indicate that pathways leading to an upregulation of
Ca responsiveness of the myofilaments are augmented while
those leading to a downregulation are diminished in genetically
hypertensive rats which would eventually favor a hypercontrac-
tile state in the coronary circulation.
Responses in intact preparations. Coronary arteries from
SHRSP exhibited an increased responsiveness to stimulation
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Figure 5. GTPyS increases Ca2" responsiveness in ,3-escin-permeabil-
ized coronary arteries. After activation with pCa 6.38, GTPyS in the
indicated concentrations was added cumulatively. Force is expressed
relative to the tension obtained at pCa 6.38 (control); values are
mean±SEM for six observations, (C) SHRSP, (0) WKY rats.
with 5-HT but not to stimulation with KCl suggesting that the
difference in the response to 5-HT was not due to a structural
modification of the blood vessels. This was supported by mor-
phometric analysis of the vessels subjected to the mechanical
experiments and by an independent study of hearts fixed under
retrograde constant pressure perfusion. It appears that coronary
arteries from 12-14-wk-old SHRSP rats with a vessel size be-
tween 100 and 430 ,tsm have not yet developed morphologic
changes. This is in accordance with findings in the superior
mesenteric artery where the dimensions of the blood vessel were
also not different in 10-12-wk-old SHR and WKY rats (35)
whereas in peripheral mesenteric arteries structural alterations
were already present in this age group (35, 36).
5-HT has a dual action on arterial tone: in the presence of
an intact endothelium, it dilates precontracted blood vessels
(16, 37); in the absence of an intact endothelium, it acts as
a vasoconstrictor (16). Therefore it could be argued that the
increased vasoconstrictor response of the intact coronary arter-
ies of the SHRSP rats to stimulation with 5-HT might be due
to a blunted endothelium-dependent vasodilatation. However,
in contrast to other species, 5-HT does not release EDRF from
endothelial cells of rat coronary arteries (38). Thus, the 5-HT
responses in this study appears to reflect the responses of the
medial smooth muscle cells themselves.
The difference in response to 5-HT and KCl suggests that
the relative contribution of pharmacomechanical and electrome-
chanical coupling to coronary artery tone differs between
SHRSP and WKY rats (see Fig. 2 B). Pharmacomechanical
coupling is associated with three events (39): the influx of Ca2"
through specific channels in the plasma membrane, release of
intracellularly stored Ca2" mediated by 1P3 and an increase in
the Ca2" responsiveness of the myofilaments. Alterations re-
lated to Ca2" influx and sarcoplasmic reticulum function have
been reported in hypertensive rats (7, 8). In addition, in SHRSP
rats, alterations in the signalling pathways involved in modulat-
ing Ca2" sensitivity may contribute to the enhanced respon-
siveness to 5-HT as discussed below.
A
0.5 mN
6 min
B
1.0-
4- 0.s-
Control WKY SHRSP
Figure 6. Forskolin relaxes submaximally activated coronary arteries at
constant Ca2+ (pCa 6.38). (A) Original tracing of a coronary artery
from SHRSP. (B) 10 iMMforskolin has a significantly smaller effect (P
< 0.05) in SHRSP. Force with forskolin is expressed relative to force
elicited by pCa 6.38 (control), values are mean±SEM; six observations.
Responses in fi-escin perneabilized preparations. As has
been described previously in other types of vascular and non-
vascular smooth muscles ( 17), the receptor-effector coupling
in fl-escin permeabilized rat coronary arteries is intact as indi-
cated by the fact that they responded to stimulation with 5-
HT with a reversible increase in force at constant submaximal
(Ca"+). The 5-HT induced increase in Ca`+ responsiveness was
probably mediated by a G protein because it was blocked by
GDP,8S which acts as a competitive inhibitor of GTP (40) and
was mimicked by GTPyS. Both the response to 5-HT and to
GTPyS was larger in the hypertensive rats. 'Ibis suggests that
the enhanced response of the intact tissue may, at least in part,
be due to the augmented Ca"+ sensitization of the smooth mus-
cle myofilaments.
The enhanced Ca2+ responsiveness observed in the hyper-
tensive animals is probably not due to alterations of the recep-
tors or the receptor G protein coupling as it is maintained when
the G proteins were directly stimulated with GTPyS. Rather it
may be due to a different G protein effector coupling whereby
the alteration may be localized at the level of the G protein or
downstream. However, it appears to be located upstream of
the contractile proteins and their immediate regulatory proteins,
myosin light chain kinase, and phosphatase, for the following
reasons. (a) GTPyS had no direct effect on the contractile
apparatus as the Ca`+ sensitizing effect was absent in triton
skinned microarteries (41 ) or after extensive permeabilization
with saponin (20), and (b) the force-calcium relationship in
the absence of an agonist or GTPyS was not different between
SHRSP and WKY rats (Fig. 3). This finding is consistent with
the previous reports showing that neither the pCa-force rela-
tionship nor Ca2+-induced myosin phosphorylation were altered
in triton-skinned tail arteries from SHRSP (24). It is also con-
sistent with the finding that the pCa-force relationship is not
altered in saponin-skinned spastic coronary arteries of miniature
pigs, which show hyperresponsiveness to histamine (42) or in
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triton skinned aortas from rats with aldosterone-salt hyperten-
sion (43).
A complete picture of the signalling cascade mediating ago-
nist induced Ca2" sensitization has yet to emerge. It has been
suggested that the G protein involved in Ca2" sensitization of
the myofilaments may not be identical to the one which leads
to the IP3 mediated Ca2" release (44). In fact, the agonist
and GTPyS induced increase in Ca2" responsiveness may be
mimicked by rhoA p21 (45) and H-ras p21 (46) which belong
to the superfamily of monomeric, low molecular weight G pro-
teins. It will therefore be interesting to see whether these mono-
meric G proteins or the proteins involved in regulating their
activity are affected in hypertension. Ras p21 may increase Ca2+
sensitivity by at least two pathways. One may be an increased
production of arachidonic acid (47). Arachidonic acid increases
Ca2+ sensitivity by inhibiting myosin light chain phosphatase
(48). It should be noted that the basal activity of myosin light
chain phosphatase itself is presumably not decreased in SHRSP
as suggested by the observation that the Ca2+ sensitivity of the
myofilaments per se is not increased in SHRSP. The second
pathway leading to Ca2+ sensitization may be the ras p21 in-
duced activation of mitogen activated kinase (MAP kinase, 49)
which in turn phosphorylates caldesmon in vitro (50) and pre-
sumably in vivo (51 ). In vitro phosphorylation of caldesmon by
MAP kinase results in weakening of the binding of caldesmon to
actin (50). Unphosphorylated caldesmon inhibits smooth mus-
cle contraction (52, 53), and therefore phosphorylation of cald-
esmon may be a mechanism to increase Ca2+ sensitivity inde-
pendent of an increase in myosin light chain phosphorylation.
In this mechanism, a PK-C-dependent pathway may play an
important role as it appears to make a large contribution to the
activation of MAP kinase by ras p21 (49). As PK-C appears
to be involved in the agonist induced increase in Ca2+ respon-
siveness (22, 23) it is interesting to note that blood vessels from
spontaneously hypertensive rats exhibit a greater sensitivity to
stimulation with phorbol esters (54, 55). Therefore, the aug-
mented agonist induced Ca2" responsiveness in SHRSP may
be due to alterations in the PK-C pathway.
The dose response curve to GTPyS is biphasic and declines
at high concentrations of GTPyS. GTPyS nonspecifically acti-
vates all G proteins in the permeabilized arteries, i.e., the one(s)
involved in calcium sensitization and Gsa the activation of which
leads to an increase in the cyclic AMP levels which decreases
the Ca2` sensitivity of coronary arteries (34). Thus, the force
response to GTPyS is the sum of the activation of sensitizing
and desensitizing pathways. It appears that at low GTPyS con-
centrations the sensitizing pathways prevail while at high con-
centrations the desensitizing pathways become more important.
It was therefore of interest to see, whether the desensitizing
pathways are also affected in the hypertensive animals.
Forskolin increases cAMP levels by directly activating the
adenylyl cyclase and acts therefore downstream of Gsa. For-
skolin relaxed f-escin-permeabilized coronary arteries at con-
stant submaximal (Ca2+). This effect was attenuated in the
genetically hypertensive rats. Therefore, the attenuated desensi-
tization to Ca2+ may in part explain the impaired /i-adrenergic
and forskolin-mediated relaxation of intact blood vessels from
hypertensive animals (56). It is at present not clear whether
the diminished response to forskolin is due to a decreased level
of cAMP (57, 58). In some cases the impaired forskolin medi-
ated relaxation appears not to involve activation mechanisms
of cAMP dependent protein kinase (56) and may therefore
involve events downstream of cAMP dependent protein kinase.
It will therefore be interesting to see whether the desensitizing
action of the catalytic subunit of cAMP dependent protein ki-
nase (34) is also impaired in SHRSP.
In conclusion we have shown that signalling pathways lead-
ing to the increase in Ca2" sensitivity of smooth muscle myofil-
aments are augmented while those leading to a decrease are
diminished in coronary arteries from SHRSP. It will be interest-
ing to see whether these alterations also occur in vascular beds
involved in blood pressure regulation such as mesenteric arter-
ies. Due to the strategies required to obtain hypertensive and
normotensive control strains, a multitude of genetic differences,
many more than the few which confer the blood pressure pheno-
type, must be expected to be present ( 15). Future studies, there-
fore, have to show whether the alterations in the Ca2" sensitivity
modulation are related to the pathogenesis of hypertension in
this animal model and/or whether they provide a link to the
coronary dysfunction of the coronary circulation seen in experi-
mental hypertension (e.g., 5). This novel mechanism may then
act synergistically to those related to the altered Ca2` homeosta-
sis of the smooth muscle cells (7, 8) and to the endothelial
dysfunction (5) in increasing coronary tone (5).
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